Will there be medical consensus that GLP-1 drugs have cardiovascular benefits beyond those provided via weight loss?
Mini
9
แน872026
71%
chance
1D
1W
1M
ALL
As implied in these tweets, among other places. Closes in 3 years.
Get แน1,000 play money
Related questions
Related questions
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
75% chance
Will a clinical trial reporting weight-loss benefits of a GLP-1 agonist be published in a major medical journal in 2024?
83% chance
Will Donald Trump ever take a GLP-1 agonist (eg Ozempic, Mounjaro, Wegovy, Zepbound, etc) for weight loss
65% chance
What fraction of US adults will regularly take GLP-1 drugs in 2030?
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by 01/01/2025?
14% chance
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
33% chance
Reliable Reporting indicating that more than 3% of Americans are taking GLP-1 agonists in 2024
36% chance
Will David Sinclair be regularly taking a SGLT2 inhibitor (canagliflozin, empagliflozin) by the end of 2025?
50% chance